Compugen cgen.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Compugen is a drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. The Company utilizes a broad and continuously growing integrated infrastructure of scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities.

Compugen is a drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. The Company utilizes a broad and continuously growing integrated infrastructure ...Show all

Company (IPO / Went public)

Phone: +972-3-765-8585

Fax:

Azrieli Center
26 Harokmim St. Bldg D
Holon, 5885849
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Compugen $25M Oct 11, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Compugen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Evergreen Venture PartnersVenture CapitalTel Aviv, IsraelOther Investors
Israel Seed PartnersVenture CapitalJerusalem, IsraelOther Investors
Apex Venture PartnersVenture CapitalChicago, Illinois, United StatesOther Investors
Giza Venture CapitalVenture CapitalTel Aviv, IsraelOther Investors
Genesis PartnersVenture CapitalPituach, IsraelOther Investors
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-pvrig antibodies and methods of use Sep 27, 2016 Jul 25, 2017 Patent
C10rf32 antibodies, and uses thereof for treatment of cancer Jan 31, 2013 Apr 11, 2017 Patent
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Aug 26, 2014 Jan 31, 2017 Patent
Polypeptides and uses thereof for treatment of autoimmune disorders and infection Jul 01, 2012 Aug 30, 2016 Patent
Heparanase splice variant Nov 30, 2010 Aug 30, 2016 Patent
See all 53 patents